Management of nausea and vomiting in patients with advanced cancer at the end of life
CPD Previous     Next

Management of nausea and vomiting in patients with advanced cancer at the end of life

Amanda Webb Macmillan clinical nurse specialist, Palliative care, Mount Vernon Cancer Centre, East and North Hertfordshire NHS Trust, Northwood, England

The prevalence of nausea and vomiting in patients with advanced cancer varies, but it generally increases towards the end of life. Nausea and vomiting can be distressing and debilitating for patients, and can affect quality of life significantly. This article discusses the assessment of nausea and vomiting, current understanding of the emetic pathways, and pharmacological management of nausea and vomiting in patients with advanced cancer at the end of life.

Correspondence amanda.webb7@nhs.net

Nursing Standard. 32, 10,53-63. doi: 10.7748/ns.2017.e10993

Received: 24 August 2017

Accepted: 19 September 2017

Published in print: 01 November 2017

Peer review

This article has been subject to external double-blind peer review and checked for plagiarism using automated software

Conflict Of Interest

None declared